Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based Pharmaceuticals
US2020046813A1
Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based Pharmaceuticals
US2018344806A1
Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based Pharmaceuticals
US2018303917A1
Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based Pharmaceuticals
US2018161407A1
Novel Method of Treating Macular Degeneration using Botulinum Toxin-Based Pharmaceuticals
CA2961217A1
Longevity enhancement induced by repetitive injections of botulinum toxin (centurion effect)
US2014105883A1
Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory beds
US2011319944A1
Submuscular Facial Fixation (Myo-Osseous Fixation) Using Microincision Microscrew Device, Injectable Glues and Adhesives, and Method and Device for Therapy of Migraine and Related Headaches
US2012039862A1
Extended length botulinum toxin formulation for human or mammalian use
CA2744015A1
Submuscular facial fixation (myo-osseous fixation) using microincision microscrew device, injectable glues and adhesives, and methods and indications for use
US2009324647A1
Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a Hyaluronidase and Methods of Use
US2010278867A1
Use of botulinum toxin for the treatment of chronic facial pain
US2007009555A1
Botulinum toxin and the treatment of primary disorders of mood and affect
US2006147471A1
Compositions, methods and devices for preparing less painful Botulinum toxin formulations
US5053005A
Chemomodulation of curvature of the juvenile spine
